It has been reported that ARHGEF3, a Rho-guanine nucleotide exchange factor (GEF) upregulated in acute myeloid leukemia (AML), modulates AML differentiation through activation of RhoA and pathways directly controlled by small GTPase family proteins [6]. Here, ARHGEF28 is linked to acute myeloid leukemia.